The Effects of Transcranial Direct Current Stimulation (tDCS) in Older Lonely Individuals

Utilizing Transcranial Direct Current Stimulation (tDCS) to Boost Social Pleasure and Participation in Older Lonely Individuals

This randomized clinical trial aims to test the effects of 10 sessions of transcranial direct current stimulation (tDCS) on social and emotional functions in lonely older adults.

The main objectives include:

• Understand whether tDCS could successfully boost positive social processing and social motivation in older adults, paralleling its effect on non-social reward processing;
• Understand whether the reduced negative and increased positive social processing in older adults would translate to an increase in real-life social activity and a decrease in loneliness feeling;
• Examine the intervention efficacy of tDCS among the aged population;
• Understand whether the tDCS effect could be long-lasting (i.e., 1 and 3 months after intervention).

Participants will be lonely older adults aged 60 or above and screened on inclusion and exclusion criteria. Eligible participants will be randomly allocated to the left dorsolateral prefrontal cortex (DLPFC) tDCS group, the right ventrolateral prefrontal cortex (VLPFC) tDCS group, or the sham control group. Participants will complete an Emotion Rating Task, questionnaires assessing their psychosocial functions, and neuropsychological tests assessing their cognitive functions at baseline, after the 5th stimulation session, immediately after the 10th stimulation session, and 1 month and 3 months after the 10th stimulation session.

Study Overview

• Status: Recruiting
• Conditions: Loneliness
• Intervention / Treatment: Device: Experimental Transcranial Direct Current Stimulation (tDCS); Device: Sham Transcranial Direct Current Stimulation (tDCS)

Detailed Description

Loneliness, or perceived social isolation, results from discrepancies between an individual's desired and achieved social needs. A substantial proportion of older adults experience loneliness. With the social distancing policies implemented during the COVID-19 pandemic, older adults, who are more likely to be functionally dependent on their caregivers, have been primarily affected, contributing to adverse impacts on their social and emotional functions. As current loneliness interventions have shown limited efficacy, it is of great significance to test novel interventions for lonely older adults.

Transcranial direct current stimulation (tDCS) is a neuromodulatory technique that has demonstrated its safety and efficacy in modulating cortical excitability and associated behaviors in older adults. It has been suggested that repeated tDCS sessions show sustained therapeutic efficacy in chronic disorders. Additionally, the efficacy of tDCS as an intervention for lonely older adults has not been investigated. As a result, it is crucial to test repeated tDCS sessions as a potential intervention to reduce loneliness and improve socioemotional functions in lonely older adults.

• Study Type: Interventional
• Enrollment (Estimated): 135
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Tatia Mei-chun LEE, PhD; Phone Number: (852) 3917-8394; Email: tmclee@hku.hk

Study Locations

• Hong Kong
  • Hong Kong, Hong Kong
    • Recruiting
    • The University of Hong Kong
    • Contact: Tatia Mei-chun LEE, PhD; Phone Number: (852) 3917-8394; Email: tmclee@hku.hk
    • Principal Investigator: Tatia Mei Chun Lee, PhD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

1. Aged ≥ 60 years old;
2. Fluent in reading and speaking Traditional Chinese (Cantonese or Mandarin);
3. Right-handed as assessed with the Edinburgh Handedness Inventory;
4. Normal or corrected-to-normal vision and hearing;
5. Normal general cognitive function as determined by the Hong Kong version of the Montreal Cognitive Assessment (HK-MoCA) ≥ 22;
6. ≥ 9 years of formal education as lexical comprehension is required in the Emotion Rating Task.

Exclusion Criteria:

1. Current or past major physical or neurological illness that significantly affects the individual's current cognitive, motor, or brain function;
2. Medication or other treatment received within 2 weeks before the study that may affect the individual's current cognitive, motor, or brain function;
3. Receiving maintained therapy that may affect cognitive, motor, or brain function and cannot be discontinued for the entire course of study;
4. Past or present major psychological conditions, including affective disorders, anxiety disorder, psychotic disorder, addiction, and impulse control disorder;
5. Any contraindication of tDCS, such as a cerebral implant or history (either personal or family) of seizure.
6. Participation in similar brain stimulation studies within the past six months.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Right VLPFC tDCS; Participants who are assigned to the right VLPFC group will receive anodal tDCS over the right ventrolateral prefrontal cortex (VLPFC).	Device: Experimental Transcranial Direct Current Stimulation (tDCS); This study will deliver tDCS sessions for ten sessions completed within two weeks. Consecutive tDCS sessions are separated by at least 24 hours. Participants assigned to one of the two experimental groups will receive 20 minutes of active stimulation with a 2mA intensity over the corresponding brain regions.
Experimental: Left DLPFC tDCS; Participants who are assigned to the right VLPFC group will receive anodal tDCS over the left dorsolateral prefrontal cortex (DLPFC).	Device: Experimental Transcranial Direct Current Stimulation (tDCS); This study will deliver tDCS sessions for ten sessions completed within two weeks. Consecutive tDCS sessions are separated by at least 24 hours. Participants assigned to one of the two experimental groups will receive 20 minutes of active stimulation with a 2mA intensity over the corresponding brain regions.
Sham Comparator: Sham Control tDCS; For the sham protocol, the electrode positioning will be randomly allocated to be identical to either the left DLPFC or the right VLPFC group, but the active stimulation will be delivered for the first 30 seconds only.	Device: Sham Transcranial Direct Current Stimulation (tDCS); This study will deliver tDCS sessions for ten sessions completed within two weeks. Consecutive tDCS sessions are separated by at least 24 hours. Participants assigned to the sham control group will receive 30 seconds of active stimulation over brain regions identical to either the left DLPFC or the right VLPFC experimental tDCS group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes in emotion and social motivation in response to social and non-social emotional stimuli	The Emotion Rating Task will assess participants' feelings and motivations upon seeing positive, negative, social, and non-social emotional words. Participants will need to rate on a scale regarding his/her emotional feelings and socializing motivation upon perceiving these words.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in self-reported loneliness levels	Perceived level of loneliness will be assessed with the brief 6-item UCLA Loneliness Scale. All items are scored on a 4-point scale ranging from 1 (never) to 4 (often). The total score ranges from 6 to 24. A higher score indicates a higher level of perceived loneliness.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes in social motivation	Participants' information-seeking and emotion-regulatory motivation will be measured with the Social Motivation Questionnaire (SMQ).	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in social anhedonia	The Dimensional Anhedonia Rating Scale (DARS) will assess participants' anhedonia in aspects including hobbies, dood/drink, social activities, and sensory experience. The participants will be instructed to provide at least two of their own examples for each pleasure domain. Participants will then be asked to rate items from 0 to 4 on a scale of not at all, slightly, moderately, mostly, and very much for each domain, with a lower score corresponding to a higher level of anhedonia.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in social participation	The Participation Measure--3 Domains, 4 Dimensions (PM-3D4D) will assess participants' social participation.	From baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in perceived social support	The Multidimensional Scale of Perceived Social Support (MSPSS) will assess participants' perceived social support. This scale includes 3 subscales: significant other, family, and friends. The mean score of the total scale can be obtained by summing across all 12 items and then dividing by 12. A higher score on the scale means a higher level of perceived social support.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in social isolation	The Abbreviated Lubben Social Network Scale (LSNS-6) will assess participants' social network size. The total score is the sum of the 6 items. Scores range from 0 to 30. A higher score indicates a lower level of social isolation.	From baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in positive and negative affect	Participants' emotional disposition and mood state will be measured with the Chinese Affect Scale (CAS). Participants will be instructed to rate on a scale from 0 to 4, with a higher score corresponding to a higher level of positive or negative affect. Scores of positive affect range from 0 to 40. Scores of negative affect range from 0 to 40.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in emotion regulation	The Cognitive Emotion Regulation Questionnaire (CERQ) will assess participants' use of nine cognitive emotion regulation strategies.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in coping styles	Coping Orientation to Problems Experienced Inventory (Brief-COPE) will assess participants' coping styles.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in approach and avoidance motivation	Participants' reward responsiveness, drive, fun-seeking, and punishment sensitivity will be assessed with the behavioral inhibition system and behavioral activation system (BIS/BAS) scale. The scale consists of 18 items that are rated on a 4-point Likert scale, with 1 = strongly disagree, 2 = disagree, 3 = agree, and 4 = strongly agree. Scores are calculated as the sum of respective items. A higher score indicates a higher approach or avoidance motivation.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in levels of depression	The Geriatric Depression Scale (GDS) will assess participants' levels of depression. Scores range from 0 to 30, with a higher score indicating a higher level of depression.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in levels of anxiety	The Geriatric Anxiety Scale - 10 Item Version (GAS-10) will assess participants' anxiety levels. Items 1 through 10 are summed to provide a total score. Each item ranges from 0 to 3. The total score ranges from 0 to 30.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in cognitive control functions	Cognitive control functions, specifically selective attention, will be assessed with the Chinese version (CST) of the Stroop Color Word Test (Victoria version).	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in processing speed	Processing Speed will be assessed with the Symbol Digit Modalities Test (SDMT).	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in working memory	The Digit Span Backward Test will assess working memory.	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.
Changes in perceived levels of social and emotional loneliness	The self-reported social and emotional loneliness levels will be measured with the 6-item De Jong Gierveld Loneliness Scale. On the negatively worded items (1 to 3, emotional loneliness), the neutral and positive answers are scored as "1". On the positively worded items (4 to 6, social loneliness), the neutral and negative answers are scored as "1". Total score ranges from 0 (least lonely) to 6 (most lonely).	From baseline to after the 5th tDCS session (1 week); from baseline to after the 10th tDCS session (2 weeks); from baseline to 1 month after the last tDCS session; from baseline to 3 months after the last tDCS session.

Collaborators and Investigators

• Sponsor: The University of Hong Kong
• Investigators: Principal Investigator: Tatia Mei-chun LEE, PhD, The University of Hong Kong

Study record dates

Study Major Dates

• Study Start (Actual): December 3, 2022
• Primary Completion (Estimated): December 1, 2024
• Study Completion (Estimated): December 1, 2025

Study Registration Dates

• First Submitted: June 8, 2023
• First Submitted That Met QC Criteria: June 29, 2023
• First Posted (Actual): July 10, 2023

Study Record Updates

• Last Update Posted (Actual): July 12, 2023
• Last Update Submitted That Met QC Criteria: July 10, 2023
• Last Verified: July 1, 2023

More Information

Terms related to this study

• Keywords: Transcranial Direct Current Stimulation; Aging; Emotion Regulation; Lateral Prefrontal Cortex
• Other Study ID Numbers: hkutdcsage

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No